Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors
Author:
Affiliation:
1. Division of Medical Oncology, Department of Internal Medicine, University of Kentucky, Lexington
2. Markey Cancer Center, University of Kentucky, Lexington
3. University of Kentucky College of Pharmacy, Lexington
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2773049/myint_2020_oi_200843_1605020849.62953.pdf
Reference36 articles.
1. Risk factors for falls among elderly persons living in the community.;Tinetti;N Engl J Med,1988
2. Prospective study of falls and risk factors for falls in adults with advanced cancer.;Stone;J Clin Oncol,2012
3. Recurrent and injurious falls in the year following hip fracture: a prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture study.;Lloyd;J Gerontol A Biol Sci Med Sci,2009
4. Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study.;Antoun;J Clin Oncol,2010
5. A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab.;Poterucha;Med Oncol,2012
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Falls in older adults during treatment for metastatic castration-resistant prostate cancer;Journal of Geriatric Oncology;2024-08
2. Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitors;JNCI: Journal of the National Cancer Institute;2024-07-25
3. Is There a Place for De-escalating Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer?;European Urology Focus;2024-07
4. Physician preferences for nonmetastatic castration-resistant prostate cancer treatment in China;Frontiers in Oncology;2024-05-21
5. EORTC 2238 “De-Escalate”: a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitors;Frontiers in Oncology;2024-05-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3